glp 1 drugs and multiple sclerosis Can GLP-1 Help People with MS? 2024 Multiple Sclerosis Highlight -
Description
You've heard the buzz about semaglutide and tirzepatide for weight loss, but let's clear up the myths
Earlier this year, Blue Cross Blue Shield said five GLP-1 drugs now account for nearly 20% of its pharmacy spend.
It is not approved for any of these yet, but the intent is clearly broader metabolic health, not just weight loss
More and more evidence is showing that the use of DPP4 Inhibitors and GLP1 Receptor Agonists in combination, is a practice worth changing
In a survey, employers told the Business Group on Health that they arent yet seeing evidence of long-term health benefits from taking GLP-1s for weight loss, leaving them unsure how to manage costs while continuing to cover them.
Medical News Today asks four experts to weigh in on the trend of trying to get a fifth dose out of Mounjaro.
